AzTrials
AzTrials

Achilles Tendon RuptureNCT06254794

Effect of BFR Rehab After Achilles Tendon Rupture

A study testing Blood flow restriction with Delfi Personalized Tourniquet System (PTS) and Physical therapy in people with Achilles Tendon Rupture, run by The Methodist Hospital Research Institute at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The purpose of this study is to determine if blood flow restriction therapy after Achilles tendon rupture reconstruction decreases post-operative calf atrophy, improves reported outcomes, and ultimately decreases return to play time. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Achilles Tendon Rupture
What is being tested?
Blood flow restriction with Delfi Personalized Tourniquet System (PTS) and Physical therapy
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
19 participants
Where
1 siteUnited States
Study dates
13 Nov 2018to Dec 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Achilles Rupture confirmed by MRI or Thompson Test
  • Adult
  • Receiving Percutaneous Achilles Repair System (PARS) or open repair
  • Proposed PT with Methodist Location

Who cannot join

  • Obesity (BMI>35)
  • Diabetes
  • Cardiovascular, renal, liver or pulmonary disease
  • Active infections
  • Cancer (current or treated within the past 2 years) or coagulation disorder
  • Physically unable to participate in the intervention
Show all 9Show fewer
  • Unable to complete a minimum of 85% of the assigned rehabilitation sessions
  • Less than 18 years of age
  • Pregnant

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

United States1 site, 1 recruiting
  • Houston Methodist Hospital

    Houston, Texas, 77030

    Haley M Goble, MHA, 7134413930, hmgoble@houstonmethodist.org

    Patrick C McCulloch, MD

    Recruiting

Other trials in United States

About this study

Official title: Effect of Blood Flow Restriction (BFR) Rehabilitation After Achilles Tendon Rupture Reconstruction

The purpose of this study is to determine if blood flow restriction therapy after Achilles tendon rupture reconstruction decreases post-operative calf atrophy, improves reported outcomes, and ultimately decreases return to play time.

Read the detailed description

The purpose of this research study is to determine if the use of Blood Flow Restriction, BFR, therapy in addition to standard physical therapy (PT) for post-Achilles tendon rupture reconstruction will decrease post-operative muscle atrophy (loss of muscle), increases dorsal and planar ankle flexion (range of motion), increase strength, and ultimately decrease return to play time for the BFR therapy group as compared to the control group.

Participants in this study will be randomly divided into either BFR group that will receive BFR therapy in addition to standard physical therapy protocol post-operatively or the control group which will undergo the standard PT protocol. All participants will complete full body composition scans (DEXA) and questionnaires before surgery, prior to physical therapy (three weeks post-op), eight weeks post-op, and 16 weeks post-op. Subjective and objective measures will be taken at physical therapy eight weeks and 16 weeks post-operatively.

Being tested
Blood flow restriction with Delfi Personalized Tourniquet System (PTS), Physical therapy
Keywords
achilles tendon rupture, blood flow restriction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Blood flow restriction with Delfi Personalized Tourniquet System (PTS)Device

    Standard of care physical therapy exercises with the use of the Delfi PTS cuff

  • Physical therapyOther

    Standard of care physical therapy exercises

Study groups in NCT06254794
Study groupRoleWhat they receive
Blood flow restriction groupExperimentalThe study group will undergo normal Achilles tendon rupture reconstruction rehab modified by use of a tourniquet for blood flow restriction during selected exercises.
Receives: Device: Blood flow restriction with Delfi Personalized Tourniquet System (PTS); Other: Physical therapy
Standard of Care (control) groupOtherThe control group will undergo the normal Achilles tendon rupture reconstruction rehab protocol as determined by Drs. Varner and McCulloch.
Receives: Other: Physical therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Muscle mass preservation

    Lean mass for lower extremity measured in kilograms (kg) using Dual-Energy-Xray-Absorptiometry (DEXA).

    Measured: pre-op, 4 weeks post op, 8 weeks post op, 16 weeks post-op

  2. Bone density preservation

    Bone mineral content measured in grams using Dual-Energy-Xray-Absorptiometry (DEXA).

    Measured: pre-op, 4 weeks post op, 8 weeks post op, 16 weeks post-op

  3. Improve patient reported outcomes (Physical activity)

    Digital RedCap survey tool sends Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function survey which consists of questions about their physical health and patient responds with Excellent, Very Good, Good, Fair or poor. Using healthmeasures.net, responses are converted to T-scores based on the general population. The highest the T-scores, the better physical health the patient has.

    Measured: pre-op, 4 weeks post op, 8 weeks post op, 16 weeks post-op

  4. Improve patient reported outcomes (Pain)

    Digital RedCap survey tool sends Pain Visual Analog Scale asking patients to rate their pain from 0 (no pain) to 100 (worst pain possible).

    Measured: pre-op, 4 weeks post op, 8 weeks post op, 16 weeks post-op

  5. Improve patient reported outcomes (Achilles tendon survey)

    Digital RedCap survey tool sends Achilles Tendon Rupture Score (ATRS) survey. This survey asks 10 questions where the patient answers from 0=major limitation to 10=No limitations. High scores point to better physical activity.

    Measured: pre-op, 4 weeks post op, 8 weeks post op, 16 weeks post-op

  6. Change in range of motion

    Physical therapy will do functional assessments including: leg squat depth, Y balance anterior, y balance posteromedial, y balance posterolateral and measure in centimeters (cm). The measurements will be taken at each physical therapy appointment and compared at the end of the study.

    Measured: Starting 4 weeks post op, patient will go to physical therapy twice a week until week 16.

  7. Change in single heel raise repetitions

    Physical therapy will count how many heel raises can be done at each timepoint.

    Measured: Starting 4 weeks post op, patient will go to physical therapy twice a week until week 16.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Feb 2024
  2. Study start13 Nov 2018
  3. Primary completionDec 2026 (estimated)
  4. Study completionDec 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
The Delfi PTS device for BFR allows for a systematic and customized approach to BFR training in the clinic. This instrument provides a digital display of pressure, inflation time, and provides the user with an interface to control the tourniquet system. Pressure is monitored and regulated continuously to compensate for changing levels in the cuff during movement. Each cuff is specifically designed for the tapered contour of a body limb (arm or leg) and sized appropriately based on body region. These cuffs only work with the Delfi PTS device and allow for comfortable pressure application. Exercise will be performed with the cuff placed around the proximal limb and inflated through the duration of activity (\~5 minutes), then immediately deflated.
Masking
None (open label)
Enrolment
19 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06254794
Sponsor's protocol ID
Pro00019305
Status last verified
Sep 2026
First submitted
22 Dec 2023
Last updated
4 Sep 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Blood flow restriction with Delfi Personalized Tourniquet System (PTS) and Physical therapy in people with Achilles Tendon Rupture, run by The Methodist Hospital Research Institute at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 4 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Haley Goble (713.441.3930, hmgoble@houstonmethodist.org), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Muscle mass preservation (time frame: pre-op, 4 weeks post op, 8 weeks post op, 16 weeks post-op). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in